Log In
Print this Print this

Seasonal quadrivalent VLP vaccine

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionQuadrivalent virus-like particle (VLP) vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat and prevent seasonal influenza
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today